United StatesTrokendi XR (topiramate extended-release) 25 mg, 30‑count prescription bottles, NDC 17772-101-30, Lot #2075801, Exp. 31‑Oct‑2029, manufactured by Catalent for Supernus Pharmaceuticals, is being recalled nationwide in the United States. The recall was issued because the product failed dissolution specifications.
What's being recalled
Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
Recalling firm: Supernus Pharmaceuticals, Inc., Rockville, MD, United States.
How to identify it
Lot # 2075801, Exp Date: 31-Oct-2029.
The hazard
Failed Dissolution Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)